BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9520293)

  • 1. Modification of ricin A chain, by addition of endoplasmic reticulum (KDEL) or Golgi (YQRL) retention sequences, enhances its cytotoxicity and translocation.
    Zhan J; Stayton P; Press OW
    Cancer Immunol Immunother; 1998 Mar; 46(1):55-60. PubMed ID: 9520293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A trans-Golgi network retention signal YQRL fused to ricin A chain significantly enhances its cytotoxicity.
    Zhan J; Ge L; Shen J; Wang K; Zheng S
    Biochem Biophys Res Commun; 2004 Jan; 313(4):1053-7. PubMed ID: 14706649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of ricin A chain and ricin A chain-KDEL in Escherichia coli.
    Zhan J; Chen Y; Wang K; Zheng S
    Protein Expr Purif; 2004 Apr; 34(2):197-201. PubMed ID: 15003251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxicity of KDEL-terminated ricin toxins correlates with distribution of the KDEL receptor in the Golgi.
    Tagge E; Chandler J; Tang BL; Hong W; Willingham MC; Frankel A
    J Histochem Cytochem; 1996 Feb; 44(2):159-65. PubMed ID: 8609372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on lysosomes degradation of ricin A chain].
    Chen C; Zhan JB; Shen FP; Shen JG
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2005 May; 34(3):212-6. PubMed ID: 15940786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addition of an ER retention signal to the ricin A chain increases the cytotoxicity of the holotoxin.
    Wales R; Chaddock JA; Roberts LM; Lord JM
    Exp Cell Res; 1992 Nov; 203(1):1-4. PubMed ID: 1426032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and characterization of the recombinant immunotoxin RTA-4D5-KDEL targeting HER2/neu-positive cancer cells and locating the endoplasmic reticulum.
    Jiao P; Zhang J; Dong Y; Wei D; Ren Y
    Appl Microbiol Biotechnol; 2018 Nov; 102(22):9585-9594. PubMed ID: 30141083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addition of an endoplasmic reticulum retrieval sequence to ricin A chain significantly increases its cytotoxicity to mammalian cells.
    Wales R; Roberts LM; Lord JM
    J Biol Chem; 1993 Nov; 268(32):23986-90. PubMed ID: 8226941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translocation of ricin A-chain into proteoliposomes reconstituted from Golgi and endoplasmic reticulum.
    Bilge A; Warner CV; Press OW
    J Biol Chem; 1995 Oct; 270(40):23720-5. PubMed ID: 7559543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrograde transport of mutant ricin to the endoplasmic reticulum with subsequent translocation to cytosol.
    Rapak A; Falnes PO; Olsnes S
    Proc Natl Acad Sci U S A; 1997 Apr; 94(8):3783-8. PubMed ID: 9108055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adapting yeast as model to study ricin toxin a uptake and trafficking.
    Becker B; Schmitt MJ
    Toxins (Basel); 2011 Jul; 3(7):834-47. PubMed ID: 22069743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dependence of ricin toxicity on translocation of the toxin A-chain from the endoplasmic reticulum to the cytosol.
    Wesche J; Rapak A; Olsnes S
    J Biol Chem; 1999 Nov; 274(48):34443-9. PubMed ID: 10567425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catalytic and cytotoxic activities of recombinant ricin A chain mutants with charged residues added at the carboxyl terminus.
    Simpson JC; Roberts LM; Lord JM
    Protein Expr Purif; 1995 Oct; 6(5):665-70. PubMed ID: 8535160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saporin and ricin A chain follow different intracellular routes to enter the cytosol of intoxicated cells.
    Vago R; Marsden CJ; Lord JM; Ippoliti R; Flavell DJ; Flavell SU; Ceriotti A; Fabbrini MS
    FEBS J; 2005 Oct; 272(19):4983-95. PubMed ID: 16176271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ricin trafficking in cells.
    Spooner RA; Lord JM
    Toxins (Basel); 2015 Jan; 7(1):49-65. PubMed ID: 25584427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ricin A chain reaches the endoplasmic reticulum after endocytosis.
    Liu Q; Zhan J; Chen X; Zheng S
    Biochem Biophys Res Commun; 2006 May; 343(3):857-63. PubMed ID: 16564502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of a potent chimeric toxin by replacement of domain III of Pseudomonas exotoxin with ricin A chain KDEL.
    Pitcher C; Roberts L; Fawell S; Zdanovsky AG; FitzGerald DJ; Lord JM
    Bioconjug Chem; 1995; 6(5):624-9. PubMed ID: 8974463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ricin A chain utilises the endoplasmic reticulum-associated protein degradation pathway to enter the cytosol of yeast.
    Simpson JC; Roberts LM; Römisch K; Davey J; Wolf DH; Lord JM
    FEBS Lett; 1999 Oct; 459(1):80-4. PubMed ID: 10508921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-glycosylation does not affect the catalytic activity of ricin a chain but stimulates cytotoxicity by promoting its transport out of the endoplasmic reticulum.
    Yan Q; Li XP; Tumer NE
    Traffic; 2012 Nov; 13(11):1508-21. PubMed ID: 22882900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single point mutation in ricin A-chain increases toxin degradation and inhibits EDEM1-dependent ER retrotranslocation.
    Sokołowska I; Wälchli S; Węgrzyn G; Sandvig K; Słomińska-Wojewódzka M
    Biochem J; 2011 Jun; 436(2):371-85. PubMed ID: 21388347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.